Prestige Consumer Healthcare (PBH) Common Equity (2010 - 2025)

Prestige Consumer Healthcare's Common Equity history runs 16 years deep, the most recent figure standing at $1.8 billion for Q4 2025.

• In Q4 2025, Common Equity rose 2.29% year-over-year to $1.8 billion; the TTM figure through Dec 2025 stood at $1.8 billion (up 2.29% YoY), while the FY2025 annual figure was $1.8 billion, up 10.86% from the prior year.
• Common Equity was $1.8 billion for Q4 2025 at Prestige Consumer Healthcare, roughly flat from $1.8 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $1.9 billion in Q2 2025 to a low of $1.4 billion in Q1 2021.
• Historically, Common Equity has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2022.
• The sharpest annual moves came in 2022 and 2023: Common Equity rose 16.15% in 2022, then decreased 8.27% in 2023.
• A 5-year view of Common Equity shows it stood at $1.5 billion in 2021, then rose by 11.1% to $1.7 billion in 2022, then dropped by 5.12% to $1.6 billion in 2023, then increased by 11.74% to $1.8 billion in 2024, then gained by 2.29% to $1.8 billion in 2025.
• The last three Common Equity figures came in at $1.8 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.9 billion (Q2 2025), per Business Quant data.